Today: 6 November 2025
Subscribe
Browse Category

Business News News 3 November 2025 - 5 November 2025

OpenAI’s DevDay Bombshells: No-Code AgentKit, ChatGPT App Store & Jony Ive’s AI Vision

OpenAI News Today (Nov 5, 2025): 1M Business Customers, SoftBank JV in Japan, and Turner’s ‘Wall‑to‑Wall’ ChatGPT Rollout

Published: November 5, 2025 TL;DR OpenAI crosses 1 million business customers OpenAI announced that more than 1 million organizations now pay for its products—either ChatGPT for Work or via its developer platform—calling it “the fastest‑growing business platform in history.” The company also highlighted momentum metrics such as 7 million total ChatGPT for Work seats (up ~40% in two months) and strong year‑over‑year growth for ChatGPT Enterprise. New enterprise capabilities span company knowledge (reasoning across tools like Slack, SharePoint, Google Drive and GitHub), rapid AgentKit development for agentic workflows, and deeper integrations (including Databricks). OpenAI Why it matters: The milestone underlines
5 November 2025
 ·  ·  ·  · 
Pfizer Stock Plunge and Promise: Vaccine Slump, Weight-Loss War, and a $10B Gamble – Is PFE Poised for a Comeback?

Pfizer Stock Plunge and Promise: Vaccine Slump, Weight-Loss War, and a $10B Gamble – Is PFE Poised for a Comeback?

Company Overview & Stock Snapshot Pfizer Inc. is one of the world’s largest pharmaceutical companies, known for household-name drugs and vaccines. Headquartered in New York, Pfizer manufactures treatments across vaccines, oncology, immunology, cardiology, and more. The company gained global prominence for its COVID-19 vaccine (Comirnaty) and antiviral pill (Paxlovid). However, with the pandemic’s tide receding, Pfizer’s stock (PFE) has faced significant challenges in 2023–2025. Shares that once traded above $50 during the vaccine rollout now hover in the mid-$20s reuters.com. At around $24–$25 per share, Pfizer’s market cap is about $138 billion stockanalysis.com – substantially smaller than several years ago
5 November 2025
 ·  ·  ·  ·  · 
China Import Expo 2025 Shatters Records: $40B Deals, US Firms Return After Xi–Trump Summit – Experts Sound Off

China Import Expo 2025 Shatters Records: $40B Deals, US Firms Return After Xi–Trump Summit – Experts Sound Off

Expo Highlights & Speeches The CIIE is China’s flagship trade fair to demonstrate “free trade credentials” and attract imports reuters.com scmp.com. Premier Li stressed high-level opening-up, promising to keep China’s economy “fairer and more transparent” reuters.com. Reuters notes Li said rising tariffs “are seriously undermining international economic and trade rules” reuters.com. He repeated China’s commitment to increase imports of “high quality products” and let global companies expand with confidence reuters.com. This year’s expo will coincide with dozens of Hongqiao Economic Forum conferences on global economic governance. Shanghai’s Liu Liang (social sciences researcher) calls the expo a chance to see “innovative technologies”
5 November 2025
 ·  ·  ·  · 
McDonald’s Q3 Earnings: Snack Wrap Comeback Drives Sales — Is Stock Primed to Soar?

McDonald’s Q3 Earnings: Snack Wrap Comeback Drives Sales — Is Stock Primed to Soar?

Robust Sales Amid Value Push McDonald’s third-quarter report topped sales forecasts, thanks largely to customer spending per visit. U.S. sales growth (2.4%) exceeded last year’s 0.3%, as diners took advantage of limited-time deals newsmax.com newsmax.com. International markets also turned in strong comps (e.g. Japan +4.7%, Germany +4.3%) newsmax.com. The company’s global systemwide sales reached over $36 billion (an 8% increase, or 6% in constant currency) prnewswire.com, reflecting both price and volume gains in company-owned and franchised restaurants. Despite the solid top-line, earnings per share slightly lagged expectations. Consolidated revenue of $7.078B grew 3% from a year ago prnewswire.com, and net
5 November 2025
 ·  ·  ·  ·  · 
AI & Quantum Frenzy Propels IBM Stock to New Heights – Will the Rally Last?

IBM’s Shock Q4 Layoffs: Thousands of Jobs Cut as Big Blue Doubles Down on AI and Software—What It Means for You and the Stock

Key facts (Nov. 5, 2025) What happened and why now IBM confirmed it is cutting jobs in the fourth quarter of 2025, affecting “thousands” of employees. The company framed the move as a routine workforce rebalance to align headcount with areas where it sees stronger, more profitable growth—namely software, hybrid cloud (Red Hat), and AI‑driven services. Reuters Bloomberg first reported the reduction and published the company’s statement: “In the fourth quarter we are executing an action that will impact a low single‑digit percentage of our global workforce.” IBM regularly reviews staffing “through this lens and at times rebalance[s] accordingly,” the
5 November 2025
 ·  ·  ·  ·  · 
Billion-Dollar Brawl: Novo Nordisk and Pfizer Clash in High-Stakes Obesity Drug Takeover

Novo Nordisk’s Weight-Loss Drug Boom Hits a Wall – Wegovy Slowdown Sparks Stock Slump and Forecast Cut

Once Sky-High Valuation Falters Amid Weight-Loss Drug Headwinds Just a year ago, Novo Nordisk – buoyed by the meteoric success of its weight-loss injection Wegovy – briefly eclipsed all other European companies in market value reuters.com. The Danish pharmaceutical giant enjoyed surging sales as Wegovy and its type-2 diabetes sibling Ozempic (both containing the GLP-1 agonist semaglutide) became global sensations, with millions seeking their dramatic weight-loss benefits. However, 2025 has seen a sharp reversal of fortune. A “slew of headwinds has shaken investor confidence” in Novo Nordisk’s once-dominant growth story stockanalysis.com. The company’s share price has plummeted nearly 50% year-to-date
5 November 2025
 ·  ·  ·  ·  · 
Axon Stock Rockets 420% Overseas as Wall Street Targets $1,000 – Should You Buy the Dip?

Axon Enterprise Rockets Past Revenue Goals – But EPS Miss Sends Stock Reeling

Q3 2025 Earnings Report Axon’s Q3 results (announced Oct. 31) beat revenue expectations but showed a small profit shortfall. The company “delivered another record quarter, with revenue growing 31% year over year to $711 million” prnewswire.com, marking its seventh straight quarter above 30% growth. Sales growth was driven by the software business – Axon’s Software & Services segment grew 41% to $305M prnewswire.com – as well as by strong demand for Tasers and body cameras. On the profitability side, Axon reported a tiny GAAP net loss of just $2.0M (–$0.03 per share) prnewswire.com, largely due to investment in staff and
4 November 2025
 ·  ·  ·  ·  · 
Tesla vs. BYD – The Ultimate 2025 EV Stock Showdown 🚀🔋

Tesla’s Top Rival Stumbles: BYD’s Profit Plunge Shakes the EV Market

From Battery Maker to EV Titan: BYD’s Meteoric Rise BYD (“Build Your Dreams”) has undergone a stunning transformation – from a humble battery producer into an electric vehicle powerhouse. The Shenzhen-based company, which started by making cellphone batteries, scaled its auto business to millions of units within a few years finanzen.net. In 2024 BYD sold about 4.27 million vehicles, firmly cementing itself among the world’s top five automakers finanzen.net. In fact, by the first half of 2025, BYD ranked #4 globally in passenger car sales – ahead of legacy giants like GM and Hyundai finanzen.net. This surge marked a tipping point,
4 November 2025
 ·  ·  ·  · 
Billion-Dollar Brawl: Novo Nordisk and Pfizer Clash in High-Stakes Obesity Drug Takeover

Billion-Dollar Brawl: Novo Nordisk and Pfizer Clash in High-Stakes Obesity Drug Takeover

Background: Novo vs. Pfizer in the Weight-Loss Drug Race The fight for Metsera is driven by fierce competition in GLP-1 obesity drugs. Novo Nordisk is the maker of Wegovy/Ozempic, and Eli Lilly’s drugs recently overtook Wegovy in US market share reuters.com. Novo’s new CEO Mike Doustdar and the company’s controlling foundation have pushed for bolder moves after days of sliding market performance reuters.com reuters.com. In late October, Novo – which had already agreed a separate $5 billion deal to buy diabetes biotech Akero – suddenly “launched a bid…valuing [Metsera] at some $9 billion and crashing Pfizer’s deal” reuters.com. This was weeks
4 November 2025
 ·  ·  ·  ·  ·  · 
Denny’s Stock Soars on Buyout Bombshell – $620 M Deal, Q3 Misses & What’s Next

Denny’s Stock Soars on Buyout Bombshell – $620 M Deal, Q3 Misses & What’s Next

Stock Price & Recent Performance Denny’s stock was under pressure for most of 2025 before the buyout news. The share price started the year in the mid-single digits and drifted lower amid uninspiring financial results and sector-wide challenges. In fact, DENN hit a 52-week low of $2.85 earlier in the year marketbeat.com, reflecting investors’ pessimism about growth prospects. By late October, the stock was trading around the $4 mark, not far from where it stood five years ago, and well off the 52-week high of $7.73 marketbeat.com reached in late 2024. In the week heading into earnings, DENN even dipped
4 November 2025
 ·  ·  ·  · 
Amazon’s $38 Billion OpenAI Deal Makes Bezos $10 B Richer and Ignites the AI Cloud Wars

Amazon’s $38 Billion OpenAI Deal Makes Bezos $10 B Richer and Ignites the AI Cloud Wars

AWS and OpenAI Ink a $38 Billion Cloud Partnership Amazon Web Services and OpenAI unveiled a multi-year cloud computing deal that ranks among the largest ever in tech. Under the agreement – valued at $38 billion over seven years – OpenAI will run and scale its advanced AI workloads on AWS’s “world-class infrastructure” starting immediately aboutamazon.com. In practical terms, AWS is provisioning OpenAI with vast computing capacity: on day one, OpenAI gains access to hundreds of thousands of NVIDIA GPU-based processors in AWS data centers, with the option to scale up to tens of millions of CPU cores for future growth arabianbusiness.com.
4 November 2025
 ·  ·  ·  · 
Nokia’s 2025 Comeback: Nvidia’s $1B AI Stake, 5G Growth & Surging Stock

Nokia’s 2025 Comeback: Nvidia’s $1B AI Stake, 5G Growth & Surging Stock

Latest News & Catalysts (Early Nov 2025) In the first week of November 2025, Nokia has dominated tech stock headlines. The biggest catalyst was Nvidia’s announcement (Oct 28, 2025) of a $1.0 billion equity investment in Nokia reuters.com. Nvidia will buy ~166 million new Nokia shares at $6.01 each, giving it a 2.9% stake reuters.com. This partnership is focused on jointly developing AI-driven networking for current 5G and future 6G systems. Notably, Nokia and Nvidia will collaborate on AI-based radio access network (AI-RAN) solutions and plan to integrate Nokia’s data center networking products (switches, optical transport) into Nvidia’s AI computing infrastructure
3 November 2025
 ·  ·  ·  ·  ·  · 
1 2 3 … 16
Go toTop